Volume 27, Number 5—May 2021
CME ACTIVITY - Dispatch
Prescribing Antimicrobial Drugs for Acute Gastroenteritis, Primary Care, Australia, 2013–2018
Table 2
Case type, drug class | No. prescriptions | Proportion of total prescriptions, % |
---|---|---|
Acute gastroenteritis, 7,159 cases | ||
Nitroimidazoles | 2980 | 41.6 |
Quinolones | 1059 | 14.8 |
Penicillins | 901 | 12.6 |
Macrolides | 799 | 11.1 |
Cephalosporins | 561 | 7.8 |
Sulfonamides and trimethoprim | 445 | 6.2 |
Tetracyclines | 295 | 4.1 |
Amphenicols |
109 |
1.5 |
Nontyphoidal Salmonella infection, 418 cases | ||
Quinolones | 127 | 30.4 |
Macrolides | 105 | 25.1 |
Penicillins | 88 | 21.0 |
Sulfonamides and trimethoprim | 59 | 14.1 |
Nitroimidazoles | 21 | 5.0 |
Cephalosporins | 13 | 3.1 |
Tetracyclines | 4 | 1.0 |
Amphenicols |
1 |
0.2 |
Campylobacter infection, 1,165 cases | ||
Macrolides | 826 | 70.9 |
Quinolones | 243 | 20.9 |
Nitroimidazoles | 58 | 5.0 |
Tetracyclines | 12 | 1.0 |
Penicillins | 10 | 0.9 |
Cephalosporins | 8 | 0.7 |
Sulfonamides and trimethoprim | 5 | 0.4 |
Amphenicols | 3 | 0.3 |
*Ten prescriptions for acute gastroenteritis are not shown: 7 for nitrofurantoin, 2 for tobramycin and 1 for methenamine.
Page created: April 22, 2021
Page updated: April 26, 2021
Page reviewed: April 26, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.